Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay N Cohn

Showing results (31-40 of 171) with videos related to

Pageof 18
Sort By:
Cardiovascular Drugs and Therapy|May 29, 2009
The president's page: target response or target doseJay N Cohn
Nature Clinical Practice. Cardiovascular Medicine|July 31, 2008
Does the angiotensin receptor blocker telmisartan prevent morbid atherosclerotic events?Jay N Cohn
ACP Journal Club|May 3, 2003
Review: concomitant aspirin use does not reduce the effectiveness of ACE inhibitorsJay N Cohn
Annals of Internal Medicine|November 21, 2012
ACP Journal Club. Fractional flow reserve-guided PCI reduced urgent revascularization at 7 months in coronary artery diseaseJay N Cohn
Expert Review of Cardiovascular Therapy|November 9, 2011
Should the blood pressure or the blood vessel be the target of therapy?Jay N Cohn
Journal of Cardiac Failure|February 18, 2004
Beta-blockers for heart failureJay N Cohn
Journal of the American College of Cardiology|August 1, 2006
Efficacy and safety in clinical trials in cardiovascular diseaseJay N Cohn
Journal of Cardiac Failure|April 16, 2013
Preventing heart failure: a critique of strategiesJay N Cohn
Journal of Cardiac Failure|March 6, 2012
What's in a name?Jay N Cohn
Trends in Cardiovascular Medicine|January 21, 2015
Prevention of cardiovascular diseaseJay N Cohn
Pageof 18

Showing results (31-40 of 171) with videos related to

Sort By:
Pageof 18
Cardiovascular Drugs and Therapy|May 29, 2009
The president's page: target response or target doseJay N Cohn
Nature Clinical Practice. Cardiovascular Medicine|July 31, 2008
Does the angiotensin receptor blocker telmisartan prevent morbid atherosclerotic events?Jay N Cohn
ACP Journal Club|May 3, 2003
Review: concomitant aspirin use does not reduce the effectiveness of ACE inhibitorsJay N Cohn
Annals of Internal Medicine|November 21, 2012
ACP Journal Club. Fractional flow reserve-guided PCI reduced urgent revascularization at 7 months in coronary artery diseaseJay N Cohn
Expert Review of Cardiovascular Therapy|November 9, 2011
Should the blood pressure or the blood vessel be the target of therapy?Jay N Cohn
Journal of Cardiac Failure|February 18, 2004
Beta-blockers for heart failureJay N Cohn
Journal of the American College of Cardiology|August 1, 2006
Efficacy and safety in clinical trials in cardiovascular diseaseJay N Cohn
Journal of Cardiac Failure|April 16, 2013
Preventing heart failure: a critique of strategiesJay N Cohn
Journal of Cardiac Failure|March 6, 2012
What's in a name?Jay N Cohn
Trends in Cardiovascular Medicine|January 21, 2015
Prevention of cardiovascular diseaseJay N Cohn
Pageof 18